P1354: CRISPR/CAS9 GENE EDITING OF IMMUNE CHECKPOINT RECEPTOR NKG2A IMPROVES THE ANTI-LEUKEMIC EFFICACY OF PRIMARY CD33-TARGETING CAR-NK CELLS.
Nawid Albinger(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Vinzenz Särchen(Goethe University Frankfurt), Jan‐Henning Klusmann(Goethe University Frankfurt), Michael A. Rieger(Goethe University Frankfurt), Ahmad Al-Ajami(Goethe University Frankfurt), R Bhayadia(Goethe University Frankfurt), Nina Möker(Miltenyi Biotec (Germany)), Jamal Alzubi(University of Freiburg), Tobias Bexte(Goethe University Frankfurt), Philipp Wendel(Goethe University Frankfurt), Meike Vogler(Goethe University Frankfurt), Toni Cathomen(University of Freiburg), Leon Buchinger(Goethe University Frankfurt), Katharina Imkeller(Goethe University Frankfurt), Alec Geßner(Goethe University Frankfurt)
Cited by 1
Related Papers
Rapid “Open-Source” Engineering of Customized Zinc-Finger Nucleases for Highly Efficient Gene Modification
|Molecular Cell|2008|709
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia
|Genes & Development|2010|218
BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation
|Blood|2011|189
The non-coding RNA landscape of human hematopoiesis and leukemia
|Nature Communications|2017|164